Agilera Pharma AS – Trademark Portfolio
Entity Type: 98
Agilera Pharma AS holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 6 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include AGILERA.
Instituttveien 18
N-2007 Kjeller
Showing of trademarks Trademarks
Trademark Classifications
Agilera Pharma AS's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Agilera Pharma AS have?
Agilera Pharma AS has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending.
What trademark classes does Agilera Pharma AS file in?
Agilera Pharma AS files trademarks across 6 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 44 (Medical Services), Class 5 (Pharmaceuticals), Class 39 (Transportation & Storage). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Agilera Pharma AS's most well-known trademarks?
Agilera Pharma AS's registered trademark portfolio includes well-known marks such as AGILERA. These are among 1 currently registered trademark in the portfolio.
What is Agilera Pharma AS's trademark registration success rate?
Agilera Pharma AS has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.